We improved how this search looks for keywords. We also adjusted search filters. For details, see Website outages and upgrades. You can also download medicine data as published on this website in table format or check our search tips for help.
To fetch data from this website via automated systems, please use our JSON data files
Search results (27239)
This page provides answers to specific questions from companies intending to apply for a paediatric investigation plan (PIP), waiver, deferral or product-specific waiver. Information is also available for companies that already have an agreed PIP.
A paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the...